|
Volumn 83, Issue 3, 2009, Pages 258-263
|
Methodology of superficial bladder cancer trials: Objective evaluation of treatment - The need for standardization
|
Author keywords
Bladder cancer; Clinical trials; Criteria standardization
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLADDER CANCER;
CANCER SURVIVAL;
CLINICAL TRIAL;
EVALUATION;
HUMAN;
MAXIMUM TOLERATED DOSE;
METHODOLOGY;
PRIORITY JOURNAL;
RELIABILITY;
REPRODUCIBILITY;
REVIEW;
STANDARDIZATION;
TRANSURETHRAL RESECTION;
CLINICAL TRIALS AS TOPIC;
HUMANS;
URINARY BLADDER NEOPLASMS;
|
EID: 70350304188
PISSN: 00421138
EISSN: None
Source Type: Journal
DOI: 10.1159/000241663 Document Type: Review |
Times cited : (3)
|
References (6)
|